Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
11%
Adverse Event
19%
Alanine Aminotransferase
9%
All Cause Mortality
10%
Alzheimer's Disease
11%
Antibiotics
10%
Antiinfective Agent
21%
Antimicrobial Resistance
11%
Antioxidant
9%
Biological Marker
20%
Bladder Cancer
18%
Bloodstream Infection
36%
Brain Ischemia
17%
Breast Cancer
20%
Calcium Ion
12%
Carcinogenesis
22%
Cardiovascular Disease
20%
Case-Control Study
11%
Cerebrovascular Accident
18%
Chemotherapy
25%
Chronic Hepatitis B
18%
Chronic Hepatitis C
14%
Chronic Kidney Failure
14%
Cisplatin
17%
Clinical Trial
10%
Cohort Study
56%
Colorectal Carcinoma
19%
Combination Therapy
18%
Comorbidity
17%
Congestive Heart Failure
12%
Cytokine
19%
Cytotoxicity
14%
Dengue
11%
Dengue Virus
9%
Diabetes Mellitus
28%
Diseases
80%
Drug Resistance
14%
End Stage Renal Disease
13%
Epidermal Growth Factor Receptor
31%
Escherichia coli
12%
Helicobacter pylori
20%
Hemodialysis
17%
Hepatitis B
16%
Hepatitis B Virus
28%
Hepatitis C
10%
Hepatitis C Virus
12%
HIV
12%
IC50
9%
Infection
57%
Infectious Agent
11%
Inflammation
28%
Integrin
12%
Interleukin 6
11%
Klebsiella pneumoniae
10%
Life Expectancy
14%
Lipopolysaccharide
13%
Liver Cancer
9%
Liver Cell Carcinoma
60%
Liver Cirrhosis
9%
Liver Injury
10%
Lung Adenocarcinoma
11%
Lung Cancer
34%
Malignant Neoplasm
92%
Messenger RNA
15%
microRNA
12%
Mitogen Activated Protein Kinase
9%
Mortality Rate
14%
Mouse Model
9%
Nanoparticle
16%
Nasopharynx Carcinoma
9%
Neoplasm
74%
Nitric Oxide
13%
Non Insulin Dependent Diabetes Mellitus
22%
Non Small Cell Lung Cancer
24%
Nonalcoholic Fatty Liver
10%
Observational Study
9%
Overall Survival
25%
Paclitaxel
9%
Parkinson's Disease
9%
Penicillinase
10%
Phosphotransferase
10%
Phthalic Acid
12%
Placebo
14%
Prevalence
29%
Progression Free Survival
14%
Prostate Cancer
11%
Protein P53
19%
Reactive Oxygen Metabolite
18%
Receptor
18%
Recurrent Disease
11%
Retrospective Study
11%
Sepsis
10%
Squamous Cell Carcinoma
11%
Statin (Protein)
10%
Survival Rate
12%
Thrombomodulin
9%
Tumor Growth
19%
Tumor Necrosis Factor
15%
Virus Infection
12%
Wound Healing
9%
Medicine and Dentistry
Adverse Event
10%
Antiinfective Agent
8%
Apoplexy
23%
Arterial Stiffness
7%
Autophagy
8%
Biological Marker
14%
Biopsy Technique
9%
Bleeding
9%
Bloodstream Infection
19%
Body Mass Index
8%
Brain Ischemia
9%
Breast Cancer
17%
Cancer
19%
Cancer Cell
17%
Carcinogenesis
8%
Cardiology
9%
Cardiovascular Disease
10%
Cardiovascular System
11%
Cell Migration
8%
Cell Signaling Pathway
9%
Cerebral Hemorrhage
8%
Chronic Hepatitis C
9%
Chronic Kidney Disease
15%
Chronic Obstructive Pulmonary Disease
8%
Clinical Trial
8%
Clinician
7%
Cohort Analysis
52%
Colorectal Carcinoma
11%
Combination Therapy
10%
Comorbidity
14%
Computer Assisted Tomography
14%
Congestive Heart Failure
9%
COVID-19
14%
Cross Sectional Study
10%
Diabetes
28%
Diabetes Mellitus
21%
Diseases
59%
Echography
7%
Emergency Department
14%
End Stage Renal Disease
14%
Endometriosis
9%
Epidermal Growth Factor Receptor
17%
Epidermolysis bullosa
21%
Epidermolysis Bullosa Dystrophica
21%
Fibroblast
9%
Gestational Age
9%
Hazard Ratio
35%
Health Care Cost
17%
Helicobacter Infection
7%
Helicobacter pylori
14%
Hemodialysis
14%
Hepatitis B Virus
11%
Hepatocellular Carcinoma
39%
Human immunodeficiency virus
10%
In Vitro
20%
Infection
36%
Intensive Care Unit
8%
Keratinocyte
9%
Life Expectancy
13%
Lifespan
13%
Logistic Regression Analysis
15%
Lung
8%
Lung Cancer
18%
Magnetic Resonance Imaging
10%
Malignant Neoplasm
33%
Maturity Onset Diabetes of the Young
14%
Medicine
7%
Meta-Analysis
21%
Metastatic Carcinoma
20%
Mortality Rate
14%
Multivariate Analysis
10%
Nasopharynx Carcinoma
8%
Neoplasm
51%
Non Small Cell Lung Cancer
15%
Odds Ratio
31%
Oral Cancer
9%
Ovarian Cancer
9%
Overall Survival
25%
Pathogen
8%
Patient with Diabetes
7%
Pediatrics
11%
Prevalence
24%
Prognostic Factor
11%
Programmed Cell Death
16%
Progression Free Survival
10%
Proportional Hazards Model
13%
Quality of Life
19%
Radiation Therapy
10%
Randomized Controlled Trial
8%
Recurrent Disease
13%
Resuscitation
12%
Retrospective Cohort Study
12%
Retrospective Study
11%
Squamous Cell Carcinoma
11%
Survival Rate
9%
Suture
9%
Systematic Review
18%
Transitional Cell Carcinoma
15%
Tumor Progression
10%
Wound Healing
8%
Keyphrases
Adjusted Hazard Ratio
5%
Adjusted Odds Ratio
5%
Alzheimer's Disease
5%
Apologizing
5%
Apoptosis
7%
Autophagy
5%
Bacteremia
7%
Bipolar Disorder
7%
Cancer Cells
5%
Chronic Hepatitis C
5%
Comorbidity
5%
Confidence Interval
27%
Diabetes
7%
Endometriosis
5%
Enterovirus 71 (EV71)
5%
Epidermal Growth Factor Receptor
5%
Epidermolysis Bullosa
18%
Hazard Ratio
12%
Helicobacter Pylori (H. pylori)
5%
Hepatocellular Carcinoma
7%
High Risk
6%
Hospitalization
5%
IL-20
7%
Induced Apoptosis
5%
Integrin
6%
Lung Cancer
7%
Meta-analysis
7%
Mortality Risk
5%
National Cohort Study
14%
Non-small Cell Lung Cancer (NSCLC)
5%
Odds Ratio
11%
Older Adults
5%
Overall Survival
6%
Overexpression
5%
Pharmaceutical Composition
5%
Polymorphism
6%
Population-based Cohort Study
11%
Quality of Life
6%
Rheumatoid Arthritis
5%
Risk Factors
8%
Signaling Pathway
5%
Southern Taiwan
7%
Taiwan
100%
Taiwanese
18%
Type 1 Diabetes Mellitus (T1DM)
5%
Type 2 Diabetes Mellitus (T2DM)
6%